Cargando…

Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis

As type 2 diabetes mellitus (T2DM) predisposes patients to endothelial cell injury and dysfunction, improvement of vascular function should be an important target for therapy. The aim of this study was to evaluate the effects of metformin, its sulfenamide and sulfonamide derivatives on selected para...

Descripción completa

Detalles Bibliográficos
Autores principales: Markowicz-Piasecka, Magdalena, Huttunen, Kristiina M., Sadkowska, Adrianna, Sikora, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982810/
https://www.ncbi.nlm.nih.gov/pubmed/31905674
http://dx.doi.org/10.3390/molecules25010125
_version_ 1783491374601994240
author Markowicz-Piasecka, Magdalena
Huttunen, Kristiina M.
Sadkowska, Adrianna
Sikora, Joanna
author_facet Markowicz-Piasecka, Magdalena
Huttunen, Kristiina M.
Sadkowska, Adrianna
Sikora, Joanna
author_sort Markowicz-Piasecka, Magdalena
collection PubMed
description As type 2 diabetes mellitus (T2DM) predisposes patients to endothelial cell injury and dysfunction, improvement of vascular function should be an important target for therapy. The aim of this study was to evaluate the effects of metformin, its sulfenamide and sulfonamide derivatives on selected parameters of endothelial and smooth muscle cell function, and platelet activity. Metformin was not found to significantly affect the viability of human umbilical vein endothelial cells (HUVECs) or aortal smooth muscle cells (AoSMC); however, it decreased cell migration by approximately 21.8% in wound healing assays after 24 h stimulation (wound closure 32.5 µm versus 41.5 µm for control). Metformin reduced platelet aggregation manifested by 19.0% decrease in maximum of aggregation (A(max)), and 20% reduction in initial platelet aggregation velocity (v(0)). Furthermore, metformin decreased spontaneous platelet adhesion by 27.7% and ADP-induced adhesion to fibrinogen by 29.6% in comparison to control. Metformin sulfenamide with an n-butyl alkyl chain (compound 1) appeared to exert the most unfavourable effects on AoSMC cell viability (IC(50) = 0.902 ± 0.015 μmol/mL), while 4-nitrobenzenesulfonamide (compound 3) and 2-nitrobenzenesulfonamide (compound 4) derivatives of metformin did not affect AoSMC and HUVEC viability at concentrations up to 2.0 μmol/mL. These compounds were also found to significantly reduce migration of smooth muscle cells by approximately 81.0%. Furthermore, sulfonamides 3 and 4 decreased the initial velocity of platelet aggregation by 11.8% and 20.6%, respectively, and ADP-induced platelet adhesion to fibrinogen by 76.3% and 65.6%. Metformin and its p- and o-nitro-benzenesulfonamide derivatives 3, 4 appear to exert beneficial effects on some parameters of vascular and platelet haemostasis.
format Online
Article
Text
id pubmed-6982810
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69828102020-02-06 Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis Markowicz-Piasecka, Magdalena Huttunen, Kristiina M. Sadkowska, Adrianna Sikora, Joanna Molecules Article As type 2 diabetes mellitus (T2DM) predisposes patients to endothelial cell injury and dysfunction, improvement of vascular function should be an important target for therapy. The aim of this study was to evaluate the effects of metformin, its sulfenamide and sulfonamide derivatives on selected parameters of endothelial and smooth muscle cell function, and platelet activity. Metformin was not found to significantly affect the viability of human umbilical vein endothelial cells (HUVECs) or aortal smooth muscle cells (AoSMC); however, it decreased cell migration by approximately 21.8% in wound healing assays after 24 h stimulation (wound closure 32.5 µm versus 41.5 µm for control). Metformin reduced platelet aggregation manifested by 19.0% decrease in maximum of aggregation (A(max)), and 20% reduction in initial platelet aggregation velocity (v(0)). Furthermore, metformin decreased spontaneous platelet adhesion by 27.7% and ADP-induced adhesion to fibrinogen by 29.6% in comparison to control. Metformin sulfenamide with an n-butyl alkyl chain (compound 1) appeared to exert the most unfavourable effects on AoSMC cell viability (IC(50) = 0.902 ± 0.015 μmol/mL), while 4-nitrobenzenesulfonamide (compound 3) and 2-nitrobenzenesulfonamide (compound 4) derivatives of metformin did not affect AoSMC and HUVEC viability at concentrations up to 2.0 μmol/mL. These compounds were also found to significantly reduce migration of smooth muscle cells by approximately 81.0%. Furthermore, sulfonamides 3 and 4 decreased the initial velocity of platelet aggregation by 11.8% and 20.6%, respectively, and ADP-induced platelet adhesion to fibrinogen by 76.3% and 65.6%. Metformin and its p- and o-nitro-benzenesulfonamide derivatives 3, 4 appear to exert beneficial effects on some parameters of vascular and platelet haemostasis. MDPI 2019-12-28 /pmc/articles/PMC6982810/ /pubmed/31905674 http://dx.doi.org/10.3390/molecules25010125 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Markowicz-Piasecka, Magdalena
Huttunen, Kristiina M.
Sadkowska, Adrianna
Sikora, Joanna
Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis
title Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis
title_full Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis
title_fullStr Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis
title_full_unstemmed Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis
title_short Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis
title_sort pleiotropic activity of metformin and its sulfonamide derivatives on vascular and platelet haemostasis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982810/
https://www.ncbi.nlm.nih.gov/pubmed/31905674
http://dx.doi.org/10.3390/molecules25010125
work_keys_str_mv AT markowiczpiaseckamagdalena pleiotropicactivityofmetforminanditssulfonamidederivativesonvascularandplatelethaemostasis
AT huttunenkristiinam pleiotropicactivityofmetforminanditssulfonamidederivativesonvascularandplatelethaemostasis
AT sadkowskaadrianna pleiotropicactivityofmetforminanditssulfonamidederivativesonvascularandplatelethaemostasis
AT sikorajoanna pleiotropicactivityofmetforminanditssulfonamidederivativesonvascularandplatelethaemostasis